Neuroanesthesia — MCQs

Q: An unconscious patient with a head injury presents to the casualty department and shows signs of raised intracranial pressure on examination. Which anesthetic agent is contraindicated in this scenario?

Ketamine. **Explanation:** In patients with head injuries and raised intracranial pressure (ICP), the primary goal of anesthetic management is to maintain cerebral perfusion pressure (CPP) while avoiding agents that further increase ICP. **Why Ketamine is the Correct Answer:** Ketamine is traditionally **contraindicated** in patients with raised ICP because it is a potent cerebral vasodilator. By increasing cerebral blood flow (CBF) and cerebral metabolic rate of oxygen ($CMRO_2$), it leads to an increase in intracranial volume and a subsequent rise in ICP. In a non-compliant skull (due to trauma or edema), this can trigger brain herniation. Additionally, Ketamine can interfere with the drainage of cerebrospinal fluid (CSF). **Analysis of Incorrect Options:** * **Thiopentone (Option A):** This is often the drug of choice for neuroprotection. It causes cerebral vasoconstriction, decreases CBF, and significantly reduces $CMRO_2$, thereby lowering ICP. * **Propofol (Option B):** Similar to Thiopentone, Propofol reduces $CMRO_2$, CBF, and ICP. It is frequently used for induction and maintenance (TIVA) in neurosurgery. * **Etomidate (Option D):** Etomidate provides hemodynamic stability while decreasing CBF and ICP. It is useful in head injury patients who are also hemodynamically unstable (hypovolemic). **High-Yield Clinical Pearls for NEET-PG:** 1. **CPP Formula:** $CPP = MAP - ICP$. Agents that decrease ICP help maintain CPP. 2. **The "Ideal" Neuro-induction Agent:** Thiopentone is the gold standard for "brain shrinkage." 3. **Exception for Ketamine:** Recent studies suggest Ketamine may be used if the patient is on controlled ventilation (preventing $CO_2$ rise), but for exam purposes, it remains the classic contraindicated agent for raised ICP. 4. **Inhalational Agents:** Nitrous Oxide ($N_2O$) also increases ICP and is generally avoided in neurotrauma.

Q: Which of the following drugs cannot reduce the cerebrospinal fluid (CSF) pressure?

Ketamine. **Explanation:** The primary determinant of intracranial pressure (ICP) and cerebrospinal fluid (CSF) pressure is the balance between cerebral blood flow (CBF), CSF production, and CSF drainage. **Why Ketamine is the correct answer:** Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow and cerebral blood volume, it leads to a significant **increase in intracranial pressure (ICP)** and CSF pressure. Additionally, it can interfere with the reabsorption of CSF. Therefore, it is traditionally contraindicated in patients with space-occupying lesions or head injuries where intracranial compliance is compromised. **Why the other options are incorrect:** * **Acetazolamide:** A carbonic anhydrase inhibitor that directly **decreases CSF production** (by up to 50%) at the choroid plexus, thereby reducing CSF pressure. * **20% Mannitol:** An osmotic diuretic that creates an osmotic gradient, drawing fluid out of the brain parenchyma into the intravascular space. It also reduces CSF production, effectively **lowering ICP**. * **Thiopentone:** A barbiturate that causes potent cerebral vasoconstriction (decreased CBF) and reduces cerebral metabolic rate ($CMRO_2$). This "coupled" reduction leads to a significant **decrease in ICP** and CSF pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Induction in Head Injury:** Etomidate or Thiopentone (if hemodynamically stable) are preferred as they reduce ICP. * **Inhalational Anesthetics:** All volatile agents (Halothane > Isoflurane) cause vasodilation and increase ICP; however, **Sevoflurane** is often preferred in neurosurgery due to its minimal effect on autoregulation at low doses. * **Exceptions for Ketamine:** Recent studies suggest that if the patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICP rise may be attenuated, but for exam purposes, it remains the classic drug that **increases ICP**.

Q: Which anesthetic agent is safe to use in a patient with increased intracranial pressure (ICP)?

Thiopentone. ### Explanation **Correct Answer: B. Thiopentone** **Why Thiopentone is correct:** Thiopentone (a barbiturate) is considered a "brain-protective" agent and is a gold standard for induction in patients with raised intracranial pressure (ICP). It works by causing **cerebral vasoconstriction**, which leads to a significant reduction in **Cerebral Blood Flow (CBF)** and **Cerebral Blood Volume (CBV)**. Consequently, this lowers the ICP. Additionally, it reduces the **Cerebral Metabolic Rate of Oxygen (CMRO2)**, protecting the brain from ischemic injury. **Why the other options are incorrect:** * **Halothane:** All volatile inhalational anesthetics are potent **cerebral vasodilators**. Halothane is the most potent vasodilator among them; it increases CBF and CBV, which significantly exacerbates intracranial hypertension. * **Ketamine:** Traditionally, Ketamine is contraindicated in head injuries because it acts as a cerebral vasodilator, increasing CBF, CMRO2, and potentially ICP (though recent evidence suggests this is minimal under controlled ventilation, it remains the "classic" wrong answer for exams). * **Ether:** Similar to halothane, ether causes significant cerebral vasodilation and increases ICP, making it unsafe for neurosurgery. **High-Yield Clinical Pearls for NEET-PG:** * **The Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone constricts vessels in healthy brain tissue, diverting blood flow toward ischemic areas where vessels are already maximally dilated. * **Drug of Choice for ICP:** While Thiopentone is the classic answer, **Propofol** is also commonly used as it similarly reduces CMRO2 and ICP. * **Etomidate:** Useful in neuro-patients with hemodynamic instability as it lowers ICP while maintaining stable blood pressure. * **Avoid Succinylcholine:** It can cause a transient rise in ICP; if used, ensure a deep plane of anesthesia or prior administration of a non-depolarizing muscle relaxant.

Q: Which of the following intravenous anesthetics causes an increase in cerebral oxygen tension?

Ketamine. ### Explanation The correct answer is **Ketamine**. **1. Why Ketamine is Correct:** Most intravenous anesthetics are "cerebro-protective" because they decrease the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and Cerebral Blood Flow (CBF). **Ketamine is the notable exception.** It acts as a potent cerebral vasodilator, significantly increasing CBF and cerebral blood volume. Because the increase in oxygen delivery (via increased blood flow) outweighs the modest increase in $CMRO_2$, it results in an overall **increase in cerebral oxygen tension ($PbtO_2$)**. **2. Why the Other Options are Incorrect:** * **Thiopentone & Propofol:** These agents cause **"Cerebral Metabolic Coupling."** They decrease $CMRO_2$ (by suppressing neuronal activity), which leads to secondary cerebral vasoconstriction and a decrease in CBF. This reduces intracranial pressure (ICP) and cerebral oxygen tension. * **Etomidate:** Similar to barbiturates, etomidate is a potent cerebral vasoconstrictor that decreases both $CMRO_2$ and CBF, making it useful for maintaining hemodynamic stability in neurosurgical patients. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inverse" Rule:** While most IV agents decrease CBF/ICP, Ketamine **increases** them. Conversely, while most inhalational agents increase CBF, Nitrous Oxide is the most potent vasodilator among them. * **Clinical Contraindication:** Traditionally, Ketamine was strictly avoided in patients with space-occupying lesions or increased ICP. However, recent evidence suggests it may be used if the patient is ventilated and co-administered with benzodiazepines or propofol. * **Drug of Choice:** **Propofol** is currently the preferred agent for neuro-induction due to its rapid recovery and effective reduction of ICP.

Q: A 10 degree Celsius decrease in body temperature causes a decrease in cerebral metabolic rate by approximately what percentage?

70%. **Explanation:** The correct answer is **70% (Option D)**. This relationship is governed by the concept of **$Q_{10}$**, which represents the factor by which a metabolic rate changes with a 10°C change in temperature. 1. **Why 70% is correct:** In the human brain, the $Q_{10}$ for the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is approximately **2 to 3**. This means that for every 10°C decrease in body temperature, the metabolic rate decreases by roughly 50% to 70%. Most standard anesthesia textbooks (like Miller’s) specify that $CMRO_2$ decreases by approximately **7% for every 1°C drop** in temperature. Therefore, a 10°C drop results in a cumulative decrease of roughly 70%. This profound reduction is the physiological basis for using **induced hypothermia** to provide neuroprotection during cardiac surgery or neurosurgery. 2. **Why other options are incorrect:** * **A (10%) & B (30%):** These values significantly underestimate the potent effect of temperature on enzymatic activity and neuronal firing. A 10-30% reduction would occur with only a 2-4°C drop. * **C (50%):** While $Q_{10}$ can be as low as 2 (representing a 50% drop), the clinical standard taught for exams is the more significant 7% per degree Celsius, making 70% the more accurate high-yield answer. **High-Yield Clinical Pearls for NEET-PG:** * **Linearity:** The relationship between temperature and $CMRO_2$ is linear between 27°C and 37°C. * **Burst Suppression:** At temperatures below 20°C, the EEG becomes isoelectric (flat), indicating a massive reduction in the "functional" component of cerebral metabolism. * **Coupling:** Under normal conditions, **Cerebral Blood Flow (CBF)** is "coupled" to $CMRO_2$. Therefore, as temperature drops and $CMRO_2$ decreases, CBF also decreases proportionally, which helps reduce intracranial pressure (ICP).

Q: Which of the following drugs does not affect the absorption and secretion of cerebrospinal fluid?

Nitrous oxide. The dynamics of Cerebrospinal Fluid (CSF) are governed by its rate of production (secretion) and its rate of reabsorption. Most anesthetic agents alter these parameters, which is a critical consideration in neuroanesthesia for managing intracranial pressure (ICP). **Explanation of the Correct Answer:** **Nitrous Oxide (N₂O)** is the correct answer because it has **no significant effect** on either the production or the reabsorption of CSF. While it is a potent cerebral vasodilator (which can increase cerebral blood volume), it remains neutral regarding CSF kinetics. **Analysis of Incorrect Options:** * **Halothane:** This volatile anesthetic **increases the resistance** to CSF reabsorption and may also increase production. This dual effect contributes to a significant rise in ICP, making it less favorable for patients with space-occupying lesions. * **Ketamine:** It is known to **increase the rate of CSF production** without significantly affecting reabsorption. This, combined with its vasodilatory effect, leads to an increase in ICP. * **Thiopentone Sodium:** Barbiturates like thiopentone **decrease the rate of CSF production**. By reducing cerebral metabolic rate (CMRO₂) and cerebral blood flow, they are traditionally used for "brain protection" and to lower ICP. **High-Yield Clinical Pearls for NEET-PG:** * **Etomidate and Propofol:** Both decrease the rate of CSF production, similar to thiopentone. * **Acetazolamide and Furosemide:** These are non-anesthetic drugs frequently tested; both **decrease** CSF production. * **Isoflurane:** Unique among volatiles as it **facilitates (increases) CSF reabsorption**, making it a preferred volatile agent in neurosurgery compared to Halothane. * **Summary Rule:** Most intravenous induction agents (except Ketamine) decrease CSF production, while most volatile agents (except Isoflurane) increase resistance to reabsorption.

Neuroanesthesia Indian Medical PG Practice Questions and MCQs

Question 1: Intracranial pressure (ICP) is raised due to:

A. Ketamine (Correct Answer)
B. Scoline
C. Halothane
D. Ether

Explanation: ### Explanation **Correct Answer: A. Ketamine** **Mechanism of Action:** Ketamine is a dissociative anesthetic that acts as an NMDA receptor antagonist. Unlike most other induction agents, Ketamine is a potent **cerebral vasodilator**. It increases Cerebral Blood Flow (CBF) and Cerebral Metabolic Rate of Oxygen ($CMRO_2$), which leads to a significant **increase in Intracranial Pressure (ICP)**. Consequently, it is generally contraindicated in patients with space-occupying lesions, head injuries, or intracranial hypertension. **Analysis of Other Options:** * **B. Scoline (Succinylcholine):** While Succinylcholine can cause a transient, mild increase in ICP (likely due to muscle fasciculations and increased CVP), it is **not** the primary answer in this context. In modern neuroanesthesia, its benefits for rapid sequence induction often outweigh this minor risk, and the effect can be blunted with defasciculating doses of non-depolarizers. * **C. Halothane:** Halothane is a potent vasodilator and can increase ICP; however, in the hierarchy of "ICP-elevating drugs" for exam purposes, Ketamine is the classic "high-yield" answer due to its profound effect on cerebral hemodynamics. * **D. Ether:** While Ether causes some vasodilation, it is obsolete in modern practice and less potent in its ICP-elevating effects compared to Ketamine. **High-Yield Clinical Pearls for NEET-PG:** * **The "Neuro-Friendly" Induction Agent:** **Thiopentone** (and Propofol) are the drugs of choice for neurosurgery as they decrease $CMRO_2$, CBF, and ICP (cerebral protection). * **Exceptions for Ketamine:** Recent studies suggest that if a patient is well-ventilated (normocapnia maintained), the ICP increase from Ketamine may be minimal, but for MCQ purposes, **Ketamine = Increased ICP**. * **Inhalational Agents:** All volatile anesthetics cause vasodilation at >1 MAC, but **Sevoflurane** is preferred over Halothane in neurosurgery because it has the least effect on cerebral autoregulation.

Question 2: An unconscious patient with a head injury presents to the casualty department and shows signs of raised intracranial pressure on examination. Which anesthetic agent is contraindicated in this scenario?

A. Thiopentone
B. Propofol
C. Ketamine (Correct Answer)
D. Etomidate

Explanation: **Explanation:** In patients with head injuries and raised intracranial pressure (ICP), the primary goal of anesthetic management is to maintain cerebral perfusion pressure (CPP) while avoiding agents that further increase ICP. **Why Ketamine is the Correct Answer:** Ketamine is traditionally **contraindicated** in patients with raised ICP because it is a potent cerebral vasodilator. By increasing cerebral blood flow (CBF) and cerebral metabolic rate of oxygen ($CMRO_2$), it leads to an increase in intracranial volume and a subsequent rise in ICP. In a non-compliant skull (due to trauma or edema), this can trigger brain herniation. Additionally, Ketamine can interfere with the drainage of cerebrospinal fluid (CSF). **Analysis of Incorrect Options:** * **Thiopentone (Option A):** This is often the drug of choice for neuroprotection. It causes cerebral vasoconstriction, decreases CBF, and significantly reduces $CMRO_2$, thereby lowering ICP. * **Propofol (Option B):** Similar to Thiopentone, Propofol reduces $CMRO_2$, CBF, and ICP. It is frequently used for induction and maintenance (TIVA) in neurosurgery. * **Etomidate (Option D):** Etomidate provides hemodynamic stability while decreasing CBF and ICP. It is useful in head injury patients who are also hemodynamically unstable (hypovolemic). **High-Yield Clinical Pearls for NEET-PG:** 1. **CPP Formula:** $CPP = MAP - ICP$. Agents that decrease ICP help maintain CPP. 2. **The "Ideal" Neuro-induction Agent:** Thiopentone is the gold standard for "brain shrinkage." 3. **Exception for Ketamine:** Recent studies suggest Ketamine may be used if the patient is on controlled ventilation (preventing $CO_2$ rise), but for exam purposes, it remains the classic contraindicated agent for raised ICP. 4. **Inhalational Agents:** Nitrous Oxide ($N_2O$) also increases ICP and is generally avoided in neurotrauma.

Question 3: Which of the following drugs cannot reduce the cerebrospinal fluid (CSF) pressure?

A. Acetazolamide
B. 20% Mannitol
C. Ketamine (Correct Answer)
D. Thiopentone

Explanation: **Explanation:** The primary determinant of intracranial pressure (ICP) and cerebrospinal fluid (CSF) pressure is the balance between cerebral blood flow (CBF), CSF production, and CSF drainage. **Why Ketamine is the correct answer:** Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow and cerebral blood volume, it leads to a significant **increase in intracranial pressure (ICP)** and CSF pressure. Additionally, it can interfere with the reabsorption of CSF. Therefore, it is traditionally contraindicated in patients with space-occupying lesions or head injuries where intracranial compliance is compromised. **Why the other options are incorrect:** * **Acetazolamide:** A carbonic anhydrase inhibitor that directly **decreases CSF production** (by up to 50%) at the choroid plexus, thereby reducing CSF pressure. * **20% Mannitol:** An osmotic diuretic that creates an osmotic gradient, drawing fluid out of the brain parenchyma into the intravascular space. It also reduces CSF production, effectively **lowering ICP**. * **Thiopentone:** A barbiturate that causes potent cerebral vasoconstriction (decreased CBF) and reduces cerebral metabolic rate ($CMRO_2$). This "coupled" reduction leads to a significant **decrease in ICP** and CSF pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Induction in Head Injury:** Etomidate or Thiopentone (if hemodynamically stable) are preferred as they reduce ICP. * **Inhalational Anesthetics:** All volatile agents (Halothane > Isoflurane) cause vasodilation and increase ICP; however, **Sevoflurane** is often preferred in neurosurgery due to its minimal effect on autoregulation at low doses. * **Exceptions for Ketamine:** Recent studies suggest that if the patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICP rise may be attenuated, but for exam purposes, it remains the classic drug that **increases ICP**.

Question 4: ICT is caused by which of the following agents?

A. Ketamine (Correct Answer)
B. Thiopentane
C. Halothane
D. Propofol

Explanation: **Explanation:** The correct answer is **Ketamine**. **Why Ketamine is correct:** Ketamine is a unique intravenous anesthetic agent that acts as an NMDA receptor antagonist. Unlike most other induction agents, Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow (CBF), it leads to an increase in cerebral blood volume, which subsequently results in an **elevation of Intracranial Tension (ICT)**. Consequently, Ketamine is generally contraindicated in patients with space-occupying lesions, head injuries, or any condition where intracranial pressure is already compromised. **Why the other options are incorrect:** * **Thiopentone (Thiopentane):** This is a barbiturate that causes potent cerebral vasoconstriction. It reduces CBF and cerebral metabolic rate ($CMRO_2$), thereby **decreasing ICT**. It is often used for "brain protection." * **Propofol:** Similar to barbiturates, Propofol reduces $CMRO_2$ and causes cerebral vasoconstriction, leading to a **decrease in ICT**. It is the preferred agent for total intravenous anesthesia (TIVA) in neurosurgery. * **Halothane:** While volatile anesthetics can increase ICT via vasodilation, the question asks for the agent most classically associated with this side effect among the given choices. In modern practice, Ketamine's effect on ICT is a more frequently tested "absolute" contraindication in neuro-anesthesia compared to the dose-dependent effects of Halothane. **High-Yield Clinical Pearls for NEET-PG:** * **The "Neuro-Friendly" Rule:** Most IV anesthetics (Thiopentone, Propofol, Etomidate) *decrease* ICT. **Ketamine is the notable exception.** * **Inhalational Agents:** All volatile agents (Halothane > Isoflurane > Sevoflurane) cause vasodilation and can increase ICT, especially at concentrations >1 MAC. * **Ketamine Exceptions:** Recent studies suggest that if a patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICT rise from Ketamine may be blunted, but for exam purposes, it remains the agent that **increases ICT**.

Question 5: Triple H therapy for subarachnoid hemorrhage consists of all the following except?

A. Hypertension
B. Hypervolemia
C. Hemodilution
D. Hypothermia (Correct Answer)

Explanation: **Explanation:** Triple H therapy is a traditional management strategy used to prevent and treat **Delayed Cerebral Ischemia (DCI)** resulting from cerebral vasospasm, which typically occurs 3–14 days after a subarachnoid hemorrhage (SAH). The primary goal is to maintain cerebral perfusion pressure (CPP) in areas where autoregulation is impaired. **Why Hypothermia is the correct answer:** **Hypothermia (Option D)** is not a component of Triple H therapy. While therapeutic hypothermia has been studied for neuroprotection, it is not part of the standard hemodynamic augmentation protocol for vasospasm and can actually lead to complications like coagulopathy and arrhythmias. **Analysis of the "Triple H" components:** * **Hypertension (Option A):** This is the most critical component. By increasing the Mean Arterial Pressure (MAP) using vasopressors (like norepinephrine), blood is forced through narrowed spastic vessels to maintain brain oxygenation. * **Hypervolemia (Option B):** Achieved through aggressive IV fluid administration to ensure adequate cardiac output. However, modern practice is shifting toward "Euvolemia" to avoid pulmonary edema. * **Hemodilution (Option C):** By slightly lowering the hematocrit (target ~30–33%), blood viscosity decreases. This improves microcirculatory flow (rheology) through the constricted cerebral arteries. **Clinical Pearls for NEET-PG:** * **Current Trend:** Modern guidelines now emphasize **"Induced Hypertension"** over the full Triple H, as hypervolemia and hemodilution often increase complications without significantly improving outcomes. * **Gold Standard Diagnosis:** Digital Subtraction Angiography (DSA) is the gold standard for detecting vasospasm, while Transcranial Doppler (TCD) is used for bedside monitoring. * **Drug of Choice:** **Nimodipine** (a calcium channel blocker) is given to all SAH patients to improve neurological outcomes, though it does not significantly reduce the incidence of radiologic vasospasm.

Question 6: Which anesthetic agent is safe to use in a patient with increased intracranial pressure (ICP)?

A. Halothane
B. Thiopentone (Correct Answer)
C. Ketamine
D. Ether

Explanation: ### Explanation **Correct Answer: B. Thiopentone** **Why Thiopentone is correct:** Thiopentone (a barbiturate) is considered a "brain-protective" agent and is a gold standard for induction in patients with raised intracranial pressure (ICP). It works by causing **cerebral vasoconstriction**, which leads to a significant reduction in **Cerebral Blood Flow (CBF)** and **Cerebral Blood Volume (CBV)**. Consequently, this lowers the ICP. Additionally, it reduces the **Cerebral Metabolic Rate of Oxygen (CMRO2)**, protecting the brain from ischemic injury. **Why the other options are incorrect:** * **Halothane:** All volatile inhalational anesthetics are potent **cerebral vasodilators**. Halothane is the most potent vasodilator among them; it increases CBF and CBV, which significantly exacerbates intracranial hypertension. * **Ketamine:** Traditionally, Ketamine is contraindicated in head injuries because it acts as a cerebral vasodilator, increasing CBF, CMRO2, and potentially ICP (though recent evidence suggests this is minimal under controlled ventilation, it remains the "classic" wrong answer for exams). * **Ether:** Similar to halothane, ether causes significant cerebral vasodilation and increases ICP, making it unsafe for neurosurgery. **High-Yield Clinical Pearls for NEET-PG:** * **The Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone constricts vessels in healthy brain tissue, diverting blood flow toward ischemic areas where vessels are already maximally dilated. * **Drug of Choice for ICP:** While Thiopentone is the classic answer, **Propofol** is also commonly used as it similarly reduces CMRO2 and ICP. * **Etomidate:** Useful in neuro-patients with hemodynamic instability as it lowers ICP while maintaining stable blood pressure. * **Avoid Succinylcholine:** It can cause a transient rise in ICP; if used, ensure a deep plane of anesthesia or prior administration of a non-depolarizing muscle relaxant.

Question 7: Which of the following intravenous anesthetics causes an increase in cerebral oxygen tension?

A. Thiopentone
B. Propofol
C. Ketamine (Correct Answer)
D. Etomidate

Explanation: ### Explanation The correct answer is **Ketamine**. **1. Why Ketamine is Correct:** Most intravenous anesthetics are "cerebro-protective" because they decrease the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and Cerebral Blood Flow (CBF). **Ketamine is the notable exception.** It acts as a potent cerebral vasodilator, significantly increasing CBF and cerebral blood volume. Because the increase in oxygen delivery (via increased blood flow) outweighs the modest increase in $CMRO_2$, it results in an overall **increase in cerebral oxygen tension ($PbtO_2$)**. **2. Why the Other Options are Incorrect:** * **Thiopentone & Propofol:** These agents cause **"Cerebral Metabolic Coupling."** They decrease $CMRO_2$ (by suppressing neuronal activity), which leads to secondary cerebral vasoconstriction and a decrease in CBF. This reduces intracranial pressure (ICP) and cerebral oxygen tension. * **Etomidate:** Similar to barbiturates, etomidate is a potent cerebral vasoconstrictor that decreases both $CMRO_2$ and CBF, making it useful for maintaining hemodynamic stability in neurosurgical patients. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inverse" Rule:** While most IV agents decrease CBF/ICP, Ketamine **increases** them. Conversely, while most inhalational agents increase CBF, Nitrous Oxide is the most potent vasodilator among them. * **Clinical Contraindication:** Traditionally, Ketamine was strictly avoided in patients with space-occupying lesions or increased ICP. However, recent evidence suggests it may be used if the patient is ventilated and co-administered with benzodiazepines or propofol. * **Drug of Choice:** **Propofol** is currently the preferred agent for neuro-induction due to its rapid recovery and effective reduction of ICP.

Question 8: Which intravenous anesthetic drug does not induce cerebral metabolism?

A. Thiopentone (Correct Answer)
B. Ketamine
C. Propofol
D. Methohexitone

Explanation: ### Explanation The primary goal in neuroanesthesia is to maintain a balance between **Cerebral Metabolic Rate of Oxygen (CMRO2)** and **Cerebral Blood Flow (CBF)**. Most intravenous anesthetics produce "cerebral metabolic coupling," where a decrease in metabolic demand leads to a proportional decrease in blood flow and intracranial pressure (ICP). **Why Thiopentone is Correct:** **Thiopentone (Option A)** is the gold standard for inducing a dose-dependent reduction in CMRO2. It suppresses neuronal activity until the EEG becomes isoelectric, at which point CMRO2 is reduced by approximately 50%. This reduction leads to cerebral vasoconstriction, decreased CBF, and decreased ICP, making it highly neuroprotective during focal cerebral ischemia. **Analysis of Incorrect Options:** * **Ketamine (Option B):** Unlike other IV agents, Ketamine is a potent cerebral vasodilator. It **increases** CMRO2, CBF, and ICP. It is generally avoided in patients with space-occupying lesions or intracranial hypertension. * **Propofol (Option C):** While Propofol *does* reduce CMRO2 and CBF (similar to Thiopentone), the question asks which drug does *not* induce (increase) metabolism. However, in the context of classic teaching and competitive exams, Thiopentone is the definitive answer for the "reduction" of metabolism, whereas Ketamine is the one that "induces" or increases it. *Note: If the question implies "which drug reduces metabolism," both A and C do so, but Thiopentone is the historical benchmark.* * **Methohexitone (Option D):** Although a barbiturate, it can activate epileptic foci and **increase** metabolic activity in certain brain regions. It is often used to prolong seizure duration during Electroconvulsive Therapy (ECT). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for ECT:** Methohexitone (due to pro-convulsant properties). * **Drug of choice for neuroprotection (focal ischemia):** Thiopentone. * **Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone shunts blood from normal brain tissue to ischemic areas by constricting vessels in healthy regions. * **Etomidate:** Also reduces CMRO2 and ICP but is associated with adrenocortical suppression.

Question 9: A 10 degree Celsius decrease in body temperature causes a decrease in cerebral metabolic rate by approximately what percentage?

A. 10%
B. 30%
C. 50%
D. 70% (Correct Answer)

Explanation: **Explanation:** The correct answer is **70% (Option D)**. This relationship is governed by the concept of **$Q_{10}$**, which represents the factor by which a metabolic rate changes with a 10°C change in temperature. 1. **Why 70% is correct:** In the human brain, the $Q_{10}$ for the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is approximately **2 to 3**. This means that for every 10°C decrease in body temperature, the metabolic rate decreases by roughly 50% to 70%. Most standard anesthesia textbooks (like Miller’s) specify that $CMRO_2$ decreases by approximately **7% for every 1°C drop** in temperature. Therefore, a 10°C drop results in a cumulative decrease of roughly 70%. This profound reduction is the physiological basis for using **induced hypothermia** to provide neuroprotection during cardiac surgery or neurosurgery. 2. **Why other options are incorrect:** * **A (10%) & B (30%):** These values significantly underestimate the potent effect of temperature on enzymatic activity and neuronal firing. A 10-30% reduction would occur with only a 2-4°C drop. * **C (50%):** While $Q_{10}$ can be as low as 2 (representing a 50% drop), the clinical standard taught for exams is the more significant 7% per degree Celsius, making 70% the more accurate high-yield answer. **High-Yield Clinical Pearls for NEET-PG:** * **Linearity:** The relationship between temperature and $CMRO_2$ is linear between 27°C and 37°C. * **Burst Suppression:** At temperatures below 20°C, the EEG becomes isoelectric (flat), indicating a massive reduction in the "functional" component of cerebral metabolism. * **Coupling:** Under normal conditions, **Cerebral Blood Flow (CBF)** is "coupled" to $CMRO_2$. Therefore, as temperature drops and $CMRO_2$ decreases, CBF also decreases proportionally, which helps reduce intracranial pressure (ICP).

Question 10: Which of the following drugs does not affect the absorption and secretion of cerebrospinal fluid?

A. Halothane
B. Nitrous oxide (Correct Answer)
C. Ketamine
D. Thiopentone sodium

Explanation: The dynamics of Cerebrospinal Fluid (CSF) are governed by its rate of production (secretion) and its rate of reabsorption. Most anesthetic agents alter these parameters, which is a critical consideration in neuroanesthesia for managing intracranial pressure (ICP). **Explanation of the Correct Answer:** **Nitrous Oxide (N₂O)** is the correct answer because it has **no significant effect** on either the production or the reabsorption of CSF. While it is a potent cerebral vasodilator (which can increase cerebral blood volume), it remains neutral regarding CSF kinetics. **Analysis of Incorrect Options:** * **Halothane:** This volatile anesthetic **increases the resistance** to CSF reabsorption and may also increase production. This dual effect contributes to a significant rise in ICP, making it less favorable for patients with space-occupying lesions. * **Ketamine:** It is known to **increase the rate of CSF production** without significantly affecting reabsorption. This, combined with its vasodilatory effect, leads to an increase in ICP. * **Thiopentone Sodium:** Barbiturates like thiopentone **decrease the rate of CSF production**. By reducing cerebral metabolic rate (CMRO₂) and cerebral blood flow, they are traditionally used for "brain protection" and to lower ICP. **High-Yield Clinical Pearls for NEET-PG:** * **Etomidate and Propofol:** Both decrease the rate of CSF production, similar to thiopentone. * **Acetazolamide and Furosemide:** These are non-anesthetic drugs frequently tested; both **decrease** CSF production. * **Isoflurane:** Unique among volatiles as it **facilitates (increases) CSF reabsorption**, making it a preferred volatile agent in neurosurgery compared to Halothane. * **Summary Rule:** Most intravenous induction agents (except Ketamine) decrease CSF production, while most volatile agents (except Isoflurane) increase resistance to reabsorption.

Practice by Chapter

Cerebral Physiology and Pathophysiology

Practice Questions

Anesthetics and Cerebral Blood Flow

Practice Questions

Intracranial Pressure Management

Practice Questions

Anesthesia for Supratentorial Craniotomy

Practice Questions

Anesthesia for Infratentorial Craniotomy

Practice Questions

Anesthesia for Traumatic Brain Injury

Practice Questions

Neuromonitoring Techniques

Practice Questions

Anesthesia for Spine Surgery

Practice Questions

Anesthesia for Neurovascular Procedures

Practice Questions

Awake Craniotomy

Practice Questions

Neuromuscular Disorders

Practice Questions

Postoperative Care in Neurosurgical Patients

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free